According to a study presented at the American Academy of Ophthalmology’s annual meeting in Chicago, investigational ...

CHICAGO -- Availability of a bevacizumab biosimilar for ophthalmic use could eliminate a lower-cost treatment option for a ...

Light therapy could be a useful treatment for the most common form of age-related macular degeneration, a new study says.

Age-related macular degeneration (AMD) is one of the leading causes of vision ... Since AMD is closely linked with aging, some researchers have turned their attention to metformin—a drug better known ...

A new statistical models shed light on why some patients can extend the dosing interval with Eylea (aflibercept) from 8 weeks ...

By squeezing Regeneron’s Eylea, eye disease drug Vabysmo has become one of the biggest growth drivers for Roche. | Despite ...

Dr. Shiri Shulman from Assuta discusses the importance of continuity in treatment during wartime and innovative therapies ...

A recent study, published in the journal Nature looked into the six-month impact of switching to faricimab instead of ...

According to Research by SNS Insider, Dry AMD Market Growth is Driven by New Therapies, Geriatric Population Boom, and Advancements in R&D.Pune, Oct. 17, 2024 (GLOBE NEWSWIRE) -- SNS Insider reports ...

Dr. Eric Guglielmo, above, recently joined Dr. Frank Venzara III and Dr. Timothy Tweito in the busy Florida Retina Specialists practice with offices in Merritt Island and Viera.

The ELEVATUM study showed clinically meaningful improvement in vision and reduction in retinal fluid in people with diabetic ...